Medicated Feed Market Trends

Medicated Feed Market Overview

Medicated Feed Market Size was valued at USD 10.6393 Billion in 2023. The medicated feed market industry is projected to grow from USD 11.20 Billion in 2024 to USD 16.13099 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.66 % during the forecast period (2024 - 2032). The medicated feed market is expanding as a result of rising concerns about animal health, rising dairy and meat consumption throughout the world, and other factors. Furthermore, the market for medicated feed additives is being driven by an increase in disease outbreaks in cattle, particularly in developing nations, which are the key market drivers enhancing market growth.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Medicated Feed Market Trends

• 
  

  Inclination rising towards animal protein is driving the market growth.

  
  

Market CAGR is driven by the inclination rising toward animal protein. Animal epidemic outbreaks and the transition of the livestock industry from an unorganized to an organized sector are the market's growth drivers. Animals need a suitable way to provide the needed medications for greater growth so that they may give people the highest-quality food, milk, and other byproducts. A reliable and complying technique is the inclusion of medications in feed. In turn, this is anticipated to fuel the Medicated Feed Additives Market's expansion throughout the ensuing years.

Regulatory organizations in several nations are becoming more and more concerned about the use of antibiotics in the food system. The European Union forbade the use of antibiotics in animal feed as early as 2006. The United States Food and Drug Administration has prohibited the addition of antibiotics to animal feed since 2017. The emphasis has switched to additional additives that can assist in reducing the utilization of antibiotics for livestock farming as more nations and regions are likely to follow suit.

Demand for medicated feed additives is anticipated to increase throughout the projection period due to concern over zoonotic and foodborne illnesses, such as different strains of bird flu. According to estimates from the European Food Safety Authority (EFSA), 320,000 instances of food-borne and zoonotic illnesses are reported in EU nations each year. The unfavorable consequences of medicated feeds are limiting market expansion. While the potential includes expanding demand for meat and poultry products and expanding animal health issues. Thus, driving the medicated feed market revenue.

Medicated Feed Market Segment Insights

Medicated Feed Type Insights

Based on type, the medicated feed market segmentation includes antioxidants, probiotics, prebiotics, amino acids, and others. The amino acids segment is the highest contributor to the market during the forecast period.  Due to rising awareness of the benefits of healthy animal diets and an increase in the frequency of animal illnesses, methionine is now utilized more frequently in animal feed, particularly for maintaining appropriate metabolic rates in cattle. DL-methionine is one of the essential amino acids. Additionally, it reduces the quantity of crude protein in the diet when added to the feed for pigs and poultry, enhancing animal health while minimizing environmental consequences. The chicken industry has been related to worries about the environment, animal welfare, and the increasing protein level in grill diets. The severity and frequency of breast blisters may increase because of a high-protein diet's potential to promote wet litter.

For an animal's tissues to avoid oxidative damage, antioxidant nutrients like beta-carotene and trace elements like selenium, copper, zinc, and manganese that are contained in enzymes are essential. This protective advantage also boosts immune function, which reduces infectious illnesses in anxious animals following transport and mastitis in dairy cows. Businesses are receiving help from several government organizations in creating BHA, which has several benefits and usage limits. For instance, Jubilant Life Sciences develops BHA, which increases the shelf life of animal feed while halting the oxidation of rancid fat. However, 200 ppm of BHA is permitted in finished feed by the US Food and Drug Administration. Antioxidants are added to prevent the long-chained marine fatty acids from oxidizing and turning rancid.

Medicated Feed Form Insights

Based on form, the medicated feed market segment includes mash, pellets, crumbled, and others. The pellets segment in the medicated feed market was experiencing steady growth and gaining popularity among livestock farmers and feed manufacturers. Pellets offer several advantages over other forms of medicated feed, such as mashed and crumbled.  Pelleting medicated feed helps improve feed efficiency as it reduces feed wastage and ensures a consistent intake of medication by animals. This can lead to better weight gain and overall performance. Pelleted medicated feed is more compact and less prone to spoilage than mashed or crumbled feed, making it easier to handle and store. This is particularly beneficial for large-scale livestock operations. When animals are given mash or crumbled feed, they may selectively eat certain components and leave out others. Pelleting helps reduce selective feeding, ensuring that animals consume the complete medicated feed, including the required medication.

Figure 1: Medicated Feed Market, by Component, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Medicated Feed Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. North America dominates the market during the forecast period. The market for medicated feed is expanding significantly in North America as a result of customers' growing demand for meat- and dairy-based foods. The United States was the world's top producer and consumer of meat products in 2022. Its regional market is anticipated to be driven by families' rising demand for dairy and animal goods.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Medicated Feed Market Share By Region 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe's medicated feed market accounts for the second-largest market share. The nation is home to several top compound feed producers, which has resulted in a rise in the need for medicated feed additives. To stop outbreaks of various illnesses in cattle, there is also an increasing focus on innovations and product line extensions in the market for medicated feed additives. The consumption of meat is higher in the UK than it is globally. Further, the German medicated feed market held the largest market share, and the UK medicated feed market was the fastest-growing market in the European region.

The Asia-Pacific Medicated Feed Market is expected to grow at the fastest CAGR from 2023 to 2032. Due to the rising demand for meat-based goods, it is projected that the Asia Pacific area would experience significant development soon. The demand for chicken and dairy-based goods is rising in nations like China and India as disposable income rises.

Businesses are boosting their R&D investment and extending their production capacity to meet the nations and South Asia’s growing need for animal protein. the integrated organic mineral manufacturing process at the new facility ensures that organic trace minerals for animals are particularly effective in a variety of combinations.

Moreover, China’s medicated feed market held the largest market share, and the Indian medicated feed market was the fastest-growing market in the Asia-Pacific region.

Medicated Feed Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development to expand their product lines, which will help the medicated feed market grow even more. Market participants are also engaging in various strategic measures to grow their businesses, and footprint, with important market developments including contractual agreements, new product launches, mergers and acquisitions, higher investments, and collaboration with other organizations. The medicated feed industry must offer cost-effective items to expand and survive in a more competitive and rising market climate.

Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the medicated feed industry to benefit clients and increase the market sector. In recent years, the medicated feed industry has offered some of the most significant medical advantages. Major players in the medicated feed market, including Cargill Inc., Hubbard Feeds, Aw Ennis, Fane Valley Ltd., Glanbia Ireland DAC, Lisavarid Co-op., Archer Daniels Midlands Co, Alltech, Paul & Vincent, Biostadt India Ltd., and others, are attempting to increase market demand by investing in research and development operations.

Cargill offers a wide range of medicated feed products tailored to meet the specific needs of different livestock species, including poultry, swine, cattle, and aquaculture. These products often contain essential nutrients, vitamins, and medications to improve animal health, growth, and productivity.  Cargill's medicated feed may include various medications, such as antibiotics, antimicrobials, coccidiostats, and other therapeutic agents. These medications are included in the feed to prevent or treat certain diseases and health issues in animals. For instance, in October 2021 Cargill presented its essential oil-infused chicken feed under the redesigned Nutrena Naturewise brand. Additionally, Yucca schidigera extract, vitamin D3, plant extracts, prebiotics, and probiotics are included in these formulations.

Hubbard Feeds provides medicated feed solutions for various livestock species, including poultry (broilers, layers, and turkeys), swine, cattle (beef and dairy), and other species. Hubbard Feeds' medicated feed products may contain a variety of medications, including antibiotics, coccidiostats, and other therapeutic agents. These medications are added to the feed to prevent or manage specific diseases and health conditions in animals. Hubbard Feeds' medicated feed offerings are formulated to provide a balanced and complete nutrition profile for animals.

Key Companies in the medicated feed market include.

• Cargill Inc.


• Hubbard Feeds


• Aw Ennis


• Fane Valley Ltd.


• Glanbia Ireland DAC


• Lisavarid Co-op.


• Archer Daniels Midlands Co


• Alltech


• Paul & Vincent


• Biostadt India Ltd.

Medicated Feed Industry Developments

November 2021: ToxFIN CARE in feed, a new product from Kemin Industries that aims to protect animal organs and tissue against mycotoxins' harm, was introduced in Europe.

October 2021: Under the upgraded Nutrena Naturewise chicken feeds brand, Cargill introduced its essential oil-infused poultry feed. Prebiotics, probiotics, plant extracts, vitamin D3, and Yucca schidigera extract are all components of these solutions.

Medicated Feed Market Segmentation

Medicated Feed Type Outlook

• Antioxidants


• Probiotics


• Prebiotics


• Amino Acids


• Others

Medicated Feed Form Outlook

• Mash


• Pellets


• Crumbled


• Others

Medicated Feed Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  

• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  

• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  

• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America